Document ID: FDA-2011-N-0002-0014
Agency: fda
Document Type: Notice
Title: Meetings: Neurological Devices Panel of the Medical Devices Advisory Committee
Posted Date: 2011-03-09T05:00Z

[Federal Register Volume 76, Number 46 (Wednesday, March 9, 2011)]
[Notices]
[Pages 12973-12974]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-5285]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0002]

Neurological Devices Panel of the Medical Devices Advisory 
Committee; Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Neurological Devices Panel of the 
Medical Devices Advisory Committee. This meeting was announced in the 
Federal Register of February 7, 2011 (76 FR 6625). The amendment is 
being

[[Page 12974]]

made to reflect a change in the Agenda portion of the document. There 
are no other changes.

FOR FURTHER INFORMATION CONTACT: Olga I. Claudio, Center for Devices 
and Radiological Health, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 66, rm. 1611, Silver Spring, MD 20993-0002, 301-
796-7608, or FDA Advisory Committee Information Line, 1-800-741-8138 
(301-443-0572 in the Washington, DC area). Please call the Information 
Line for up-to-date information on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of February 7, 2011, 
FDA announced that a meeting of the Neurological Devices Panel of the 
Medical Devices Advisory Committee would be held on March 17 and 18, 
2011. On page 6625, in the second column, in the last paragraph, in the 
first and second sentences, the ``for the NovoTTF-100A Treatment Kit, 
sponsored by Hogan Lovells US LLP for NovoCure, Ltd. The NovoTTF-100A 
Treatment Kit'' portion of the document is changed to read as follows: 
``for the NovoTTF-100A System, sponsored by NovoCure, Ltd. The NovoTTF-
100A System''.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: March 3, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-5285 Filed 3-8-11; 8:45 am]
BILLING CODE 4160-01-P